©2019 by Nocimetrics. Proudly created with Wix.com

Accelerating the drug discovery pipeline
High throughput  •  Automated  •  High sensitivity

BETTER MODELS = BETTER DRUGS

New pain medications are developed at among the slowest rates in medical research. Drug development can fail because current preclinical models do not capture how pain affects human behaviour and well-being. 

 

We believe in using the right models to develop the right drugs

 

Our automated testing system uses Artificial Intelligence and machine learning algorithms to measure natural behaviours associated with pain and illness in pre-clinical models, allowing precise and accurate drug discovery.

Pot-Leaf-Flora-Hash-Marijuana-Cannabis-3
Illness-Pain-Capsule-Pill-Medication-Med
Lab_mouse_mg_3263.jpg

CANNABIS RESEARCH

OPIOID ALTERNATIVES

PRECLINICAL TOXICOLOGY

 

ROBERT BONIN, PHD

Founder and CSO

Professor of Pharmacy at the University of Toronto.

IRENE LECKER, PHD

Chief Technology Officer

Postdoctoral Fellow at the University of Toronto

HANTAO ZHANG

Lead Scientific Officer

PhD Student at the University of Toronto

 
 

CONTACT NOCIMETRICS

1004-144 College St, Toronto, Ontario. M5S 3M2